Defendant

Bank of America Corporation

2 cases as defendant.

Company profile

Bank of America Corporation, commonly known as Bank of America (BofA), is a major American multinational investment bank and financial services holding company. Headquartered in Charlotte, North Carolina, the modern company was formed by the 1998 merger of NationsBank and BankAmerica, with a history tracing back to the Bank of Italy, founded in 1904 in San Francisco. Bank of America is a publicly traded company listed on the New York Stock Exchange under the ticker symbol BAC. As one of the largest banking institutions in the United States, it reported revenues of over $100 billion and employed approximately 213,000 people in 2024.

As a diversified financial services company, Bank of America operates through several business segments. Its offerings for individual consumers and small businesses include checking and savings accounts, credit cards, and mortgage and auto loans. The company is also a global leader in wealth management, investment banking, and trading, serving corporations, governments, and institutions. Its major divisions and brands include Merrill (formerly Merrill Lynch) for investment and wealth management and Bank of America Private Bank. The company serves approximately 70 million clients through a network of around 3,500 retail financial centers and 15,000 ATMs, supplemented by extensive digital banking platforms.

Based on the provided litigation data, Bank of America's patent-litigation posture is that of an operating company defending its products and services against infringement claims. The company has been tracked as a defendant in one patent case and has not appeared as a plaintiff. This pattern is typical for large technology-implementing companies that are targets for patent assertion entities.

The single tracked case, Disintermedation Services Inc. v. Bank of America Corporation, was filed in the U.S. District Court for the District of Delaware in 2022. This case positions Bank of America as a defendant against an entity whose name suggests a focus on patent licensing or assertion rather than product development, a common scenario for large financial institutions that deploy customer-facing technology.